Skip to main content

letter

. 1995 Dec 16;311(7020):1641. doi: 10.1136/bmj.311.7020.1641a

Deciding which selective serotonin reuptake inhibitor to prescribe.

PMCID: PMC2551529 PMID: 8555826

1641

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Anderson I. M., Tomenson B. M. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ. 1995 Jun 3;310(6992):1433–1438. doi: 10.1136/bmj.310.6992.1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
Leonard B. E. Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance. Drugs. 1992;43 (Suppl 2):3–10. doi: 10.2165/00003495-199200432-00003. [DOI] [PubMed] [Google Scholar]
Song F., Freemantle N., Sheldon T. A., House A., Watson P., Long A., Mason J. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ. 1993 Mar 13;306(6879):683–687. doi: 10.1136/bmj.306.6879.683. [DOI] [PMC free article] [PubMed] [Google Scholar]
Stokes P. E. Fluoxetine: a five-year review. Clin Ther. 1993 Mar-Apr;15(2):216–215. [PubMed] [Google Scholar]

ACTIONS

RESOURCES